Characterization of Polysaccharide Antigens from Enterococci
Author Information
Author(s): Carolyn T Hsu, Amanda L Ganong, Barbara Reinap, Zafiria Mourelatos, Johannes Huebner, Julia Y Wang
Primary Institution: Brigham and Women's Hospital, Harvard Medical School
Hypothesis
Do enterococci express different polysaccharide antigens that can be used for vaccine development?
Conclusion
The study found that six clinical strains of enterococci express unique cell-surface heteroglycans that could be used for serotyping and vaccine development.
Supporting Evidence
- Enterococci are major nosocomial pathogens due to their antibiotic resistance.
- The study isolated three types of polysaccharides from each strain.
- Heteroglycans were found to be the most abundant polysaccharides.
Takeaway
Scientists studied bacteria called enterococci to find special sugars on their surface that could help make vaccines. They found that each strain has its own unique sugars.
Methodology
The researchers isolated polysaccharides from six strains of enterococci, analyzed their structures, and tested their immunogenicity.
Limitations
The study did not assess the long-term immunogenicity or protective efficacy of the polysaccharides in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website